BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34465865)

  • 1. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.
    Niederkorn M; Ishikawa C; M Hueneman K; Bartram J; Stepanchick E; R Bennett J; E Culver-Cochran A; Bolanos LC; Uible E; Choi K; Wunderlich M; Perentesis JP; M Chlon T; Filippi MD; Starczynowski DT
    Leukemia; 2022 Feb; 36(2):438-451. PubMed ID: 34465865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis.
    Niederkorn M; Hueneman K; Choi K; Varney ME; Romano L; Pujato MA; Greis KD; Inoue JI; Meetei R; Starczynowski DT
    Cell Rep; 2020 Feb; 30(8):2776-2790.e6. PubMed ID: 32101751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1/Nrf2 signaling.
    Xu E; Yin C; Yi X; Liu Y
    Environ Toxicol; 2022 Apr; 37(4):765-775. PubMed ID: 34931430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circADAM9 Promotes Inflammation, Oxidative Stress, and Fibrosis of Human Mesangial Cells via the Keap1-Nrf2 Pathway in Diabetic Nephropathy.
    Zheng H; Liu X; Song B
    Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):491-499. PubMed ID: 37463596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells.
    van den Berk P; Lancini C; Company C; Serresi M; Sanchez-Bailon MP; Hulsman D; Pritchard C; Song JY; Schmitt MJ; Tanger E; Popp O; Mertins P; Huijbers IJ; Jacobs H; van Lohuizen M; Gargiulo G; Citterio E
    Cell Rep; 2020 Dec; 33(13):108533. PubMed ID: 33378683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP15 participates in DBP-induced testicular oxidative stress injury through regulating the Keap1/Nrf2 signaling pathway.
    Zhang L; Gao X; Qin Z; Shi X; Xu K; Wang S; Tang M; Wang W; Gao S; Zuo L; Zhang L; Zhang W
    Sci Total Environ; 2021 Aug; 783():146898. PubMed ID: 34088152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP15 negatively regulates Nrf2 through deubiquitination of Keap1.
    Villeneuve NF; Tian W; Wu T; Sun Z; Lau A; Chapman E; Fang D; Zhang DD
    Mol Cell; 2013 Jul; 51(1):68-79. PubMed ID: 23727018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
    Karathedath S; Rajamani BM; Musheer Aalam SM; Abraham A; Varatharajan S; Krishnamurthy P; Mathews V; Velayudhan SR; Balasubramanian P
    PLoS One; 2017; 12(5):e0177227. PubMed ID: 28505160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of USP15 Prevent Glutamate-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway in HT22 Cells.
    Chen X; Bao G; Liu F
    Cell Mol Neurobiol; 2020 Aug; 40(6):999-1010. PubMed ID: 31933062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.
    Nguyen LXT; Troadec E; Kalvala A; Kumar B; Hoang DH; Viola D; Zhang B; Nguyen DQ; Aldoss I; Ghoda L; Budde E; Pichiorri F; Rosen S; Forman SJ; Marcucci G; Pullarkat V
    J Cell Physiol; 2019 Aug; 234(8):14040-14049. PubMed ID: 30623427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
    Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
    Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.
    Shah NM; Zaitseva L; Bowles KM; MacEwan DJ; Rushworth SA
    Cell Death Differ; 2015 Apr; 22(4):654-64. PubMed ID: 25323587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
    Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
    J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quantitative Proteomics Approach to Gain Insight into NRF2-KEAP1 Skeletal Muscle System and Its Cysteine Redox Regulation.
    Abu R; Yu L; Kumar A; Gao L; Kumar V
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEAP1/NRF2 axis regulates H
    He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
    Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells.
    Sun Q; Zhang Z; Lu Y; Liu Q; Xu X; Xu J; Liu Y; Yu H; Yu D; Sun B
    Hepatology; 2020 Jun; 71(6):2033-2049. PubMed ID: 31578733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.